Hematology

A captivating session, presented at EHA Congress 2023, on sickle cell disease explored the role of allogeneic stem cell transplantation in this condition, as well as gene therapy and gene editing in treating patients with SCD.

Lymphoma experts presented an insightful exploration of clinical trial data on immunotherapy and targeted therapeutics for diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.

THE EUROPEAN Hematology Association (EHA) successfully brought together clinicians and researchers from all over the world to share the latest advances in the field of haematology in its 27th Annual Congress, and its first ever hybrid congress.

MILLIONS of women across the world opt for hormone-based therapies for contraception, and as a replacement therapy for relieving symptoms…

THE GLOBAL community of clinicians and researchers shared in the latest advances in haematology care online at the 26th European Hematology Association (EHA) 2021 Virtual Congress.

EMJ sits down with Ruud Delwel, Chair of  the Scientific Program Committee, European Hematology Association (EHA) 2021 Virtual Congress.

ON DAY 6 of the European Hematology Association (EHA) Virtual Congress 2021, Pieter Sonneveld, Professor of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands, chaired the European Society for Medical Oncology and EHA (ESMO-EHA) joint session on clinical practice guidelines for the diagnosis, treatment, and follow-up of multiple myeloma.

AT THE EUROPEAN Hematology Association (EHA) 2021 Virtual Congress, Evangelos Terpos, University of Athens School of Medicine, Greece, discussed COVID-19 and how neutralising antibody levels are affected by various factors such as age, gender, and disease.